var singsData = [{"date":new Date(2012,1,17),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Morgan Keegan upgrades CFN to Outperform from Market Perform. Target Price is $31; previously $26.","showOnAxis":false},{"date":new Date(2012,1,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Scotiabank maintains CFN to Sector Outperform. Target Price is $215; previously $190.","showOnAxis":false},{"date":new Date(2012,10,20),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus initiates coverage on CFN to Buy. Target Price is $33.","showOnAxis":false},{"date":new Date(2012,10,8),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, CFN reports 2013 Q1's earning $0.37 per share and revenue $837MM..","showOnAxis":false},{"date":new Date(2012,11,13),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains CFN to Buy. Target Price is $32; previously $30.","showOnAxis":false},{"date":new Date(2012,4,9),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, CFN reports 2012 Q3's earning $0.14 per share and revenue $919MM..","showOnAxis":false},{"date":new Date(2012,7,10),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains CFN to Buy. Target Price is $30; previously $28.","showOnAxis":false},{"date":new Date(2012,7,9),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"CFN reports 2012 Q4's earning $0.51 per share and revenue $968MM. This beats analyst's estimated EPS $0.5, beats estimated revenue $959.95MM.","showOnAxis":false},{"date":new Date(2012,8,10),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs maintains CFN to Neutral. Target Price is $28; previously $27.","showOnAxis":false},{"date":new Date(2012,8,6),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains CFN to Buy. Target Price is $30; previously $29.","showOnAxis":false},{"date":new Date(2013,0,18),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains CFN to Buy. Target Price is $34; previously $32.","showOnAxis":false},{"date":new Date(2013,0,3),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Morgan Stanley downgrades CFN to Equal-Weight from Overweight.","showOnAxis":false},{"date":new Date(2013,0,4),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains CFN to Hold. Target Price is $32; previously $28.","showOnAxis":false},{"date":new Date(2013,1,20),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains CFN to Equal-Weight. Target Price is $36; previously $32.","showOnAxis":false},{"date":new Date(2013,1,7),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, CFN reports 2013 Q2's earning $0.54 per share and revenue $909MM. This beats analyst's estimated EPS $0.44, beats estimated revenue $908.4MM.","showOnAxis":false},{"date":new Date(2013,1,8),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Credit Agricole downgrades CFN to Outperform from Buy. Target Price is $36; previously $30.","showOnAxis":false},{"date":new Date(2013,1,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"BMO Capital maintains CFN to Outperform. Target Price is $35; previously $34.","showOnAxis":false},{"date":new Date(2013,1,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains CFN to Equal-Weight. Target Price is $32; previously $28.","showOnAxis":false},{"date":new Date(2013,1,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus maintains CFN to Buy. Target Price is $37; previously $33.","showOnAxis":false},{"date":new Date(2013,10,7),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, CFN reports 2014 Q1's earning $0.44 per share and revenue $830MM. This beats analyst's estimated EPS $0.39, beats estimated revenue $818.69MM.","showOnAxis":false},{"date":new Date(2013,11,17),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Goldman Sachs downgrades CFN to Sell from Neutral. Target Price is $36; previously $35.","showOnAxis":false},{"date":new Date(2013,11,18),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Bank of America maintains CFN to Buy. Target Price is $45; previously $43.","showOnAxis":false},{"date":new Date(2013,3,12),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains CFN to Hold. Target Price is $35; previously $34.","showOnAxis":false},{"date":new Date(2013,4,9),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, CFN reports 2013 Q3's earning $0.59 per share and revenue $901MM. This beats analyst's estimated EPS $0.53, misses estimated revenue $907.8MM.","showOnAxis":false},{"date":new Date(2013,6,12),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains CFN to Overweight. Target Price is $41; previously $35.","showOnAxis":false},{"date":new Date(2013,6,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"BMO Capital maintains CFN to Outperform. Target Price is $42; previously $48.","showOnAxis":false},{"date":new Date(2013,7,8),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, CFN reports 2013 Q4's earning $0.55 per share and revenue $903MM. This misses analyst's estimated EPS $0.56, misses estimated revenue $918.25MM.","showOnAxis":false},{"date":new Date(2013,7,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus maintains CFN to Buy. Target Price is $42; previously $37.","showOnAxis":false},{"date":new Date(2014,4,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Raymond James maintains CFN to Strong Buy. Target Price is $50; previously $48.","showOnAxis":false},{"date":new Date(2014,4,6),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Goldman Sachs upgrades CFN to Neutral from Sell. Target Price is $40; previously $37.","showOnAxis":false},{"date":new Date(2014,4,6),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains CFN to Equal-Weight. Target Price is $42; previously $44.","showOnAxis":false},{"date":new Date(2014,7,15),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Raymond James maintains CFN to Strong Buy. Target Price is $52; previously $50.","showOnAxis":false},{"date":new Date(2014,7,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"BMO Capital maintains CFN to Outperform. Target Price is $48; previously $46.","showOnAxis":false},{"date":new Date(2014,7,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains CFN to Overweight. Target Price is $48; previously $44.","showOnAxis":false},{"date":new Date(2014,7,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus maintains CFN to Buy. Target Price is $49; previously $42.","showOnAxis":false},{"date":new Date(2014,9,22),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Raymond James downgrades CFN to Market Perform from Strong Buy; previously $52.","showOnAxis":false},{"date":new Date(2014,9,6),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"PiperJaffray downgrades CFN to Neutral from Overweight. Target Price is $48; previously $38.","showOnAxis":false},{"date":new Date(2014,9,7),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"JP Morgan downgrades CFN to Neutral from Overweight. Target Price is $59; previously $48.","showOnAxis":false}];